Medidata Solutions (NASDAQ:MDSO) updated its FY 2019 earnings guidance on Tuesday. The company provided earnings per share guidance of $1.71-1.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.84. The company issued revenue guidance of $734-746 million, compared to the consensus revenue estimate of $749.49 million.
MDSO has been the topic of several research analyst reports. Zacks Investment Research cut Medidata Solutions from a buy rating to a hold rating in a report on Monday. BidaskClub cut Medidata Solutions from a buy rating to a hold rating in a report on Monday, January 7th. Leerink Swann initiated coverage on Medidata Solutions in a report on Wednesday, January 2nd. They set a market perform rating and a $70.00 price target on the stock. JPMorgan Chase & Co. cut Medidata Solutions from a neutral rating to an underweight rating in a report on Thursday, December 13th. Finally, TheStreet cut Medidata Solutions from a b rating to a c+ rating in a report on Thursday, December 20th. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the company. Medidata Solutions has an average rating of Hold and a consensus price target of $83.73.
Shares of Medidata Solutions stock opened at $74.23 on Tuesday. Medidata Solutions has a one year low of $60.10 and a one year high of $88.87. The firm has a market capitalization of $4.48 billion, a P/E ratio of 87.33, a P/E/G ratio of 4.23 and a beta of 1.32. The company has a current ratio of 2.52, a quick ratio of 2.52 and a debt-to-equity ratio of 0.15.
In related news, CFO Rouven Bergmann sold 10,000 shares of the firm’s stock in a transaction on Monday, December 3rd. The stock was sold at an average price of $79.00, for a total value of $790,000.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert Taylor sold 2,120 shares of the firm’s stock in a transaction on Monday, January 7th. The stock was sold at an average price of $64.70, for a total value of $137,164.00. Following the completion of the transaction, the director now directly owns 41,916 shares in the company, valued at $2,711,965.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 41,632 shares of company stock worth $3,126,704. 4.70% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: This piece was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2019/02/12/medidata-solutions-mdso-updates-fy-2019-earnings-guidance.html.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.